National Cancer Institute

Funding Opportunities

Sponsor Recent deadline Title Deadline 2 Deadline 3 FOA
National Cancer Institute (NCI) 4/7/2022 Core Infrastructure Support for Cancer Epidemiology Cohorts (U01 Clinical Trial Not Allowed) 11/9/2022 PAR-20-294
National Cancer Institute (NCI) 4/22/2022 Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) 9/22/2022 RFA-CA-22-002
National Cancer Institute (NCI) 4/22/2022 Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed) 9/22/2022 RFA-CA-22-001
National Cancer Institute (NCI) 5/25/2022 Cancer Research Education Grants Program – Courses for Skills Development (R25 Clinical Trial Not Allowed) 9/25/2022 PAR-21-278
National Cancer Institute (NCI) 5/25/2022 Cancer Research Education Grants Program – Research Experiences (R25 Clinical Trial Not Allowed) 9/25/2022 PAR-21-279
National Cancer Institute (NCI) 5/25/2022 National Cancer Institute Program Project Applications (P01 Clinical Trial Optional) 5/25/2022 9/25/2022 PAR-20-077
National Cancer Institute (NCI) 6/5/2022 Leveraging Cognitive Neuroscience to Improve Assessment of Cancer Treatment-Related Cognitive Impairment (R21 Clinical Trial Optional) PAR-19-339
National Cancer Institute (NCI) 6/5/2022 Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (R01 Clinical Trial Optional) 10/5/2022 2/5/2023 PAR-22-099
National Cancer Institute (NCI) 6/5/2022 Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility (R01 Clinical Trial Not Allowed) 10/5/2022 2/5/2023 PAR-22-083
National Cancer Institute (NCI) 6/5/2022 Molecular Imaging of Inflammation in Cancer (R01 Clinical Trial Not Allowed) 10/5/2022 2/5/2023 PAR-21-294

Can’t find what you’re looking for? Please contact Researchadmin@cancer.ufl.edu for assistance in finding additional funding opportunities.